{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:14:36Z","timestamp":1787868876318,"version":"build-2784847793"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11764-022-01220-0","type":"journal-article","created":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T03:28:22Z","timestamp":1653708502000},"page":"1760-1768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Long-term changes of cognitive impairment among older breast cancer survivors"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8901-4462","authenticated-orcid":false,"given":"Juhua","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Schousboe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine E.","family":"Ensrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hendryx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,28]]},"reference":[{"key":"1220_CR1","unstructured":"ACS, Breast Cancer Facts & Figures 2019\u20132020 https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/breast-cancer-facts-and-figures\/breast-cancer-facts-and-figures-2019-2020.pdf. 2021, American Cancer Society (ACS)."},{"issue":"10","key":"1220_CR2","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1200\/Jco.2004.04.173","volume":"22","author":"CH Kroenke","year":"2004","unstructured":"Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz GA, Holmes MD. Functional impact of breast cancer by age at diagnosis. J Clin Oncol. 2004;22(10):1849\u201356. https:\/\/doi.org\/10.1200\/Jco.2004.04.173.","journal-title":"J Clin Oncol"},{"issue":"11","key":"1220_CR3","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1002\/1097-0142(20001201)89:11<2176::aid-cncr5>3.0.co;2-6","volume":"89","author":"YL Michael","year":"2000","unstructured":"Michael YL, Kawachi I, Berkman LF, Holmes MD, Colditz GA. The persistent impact of breast carcinoma on functional health status: prospective evidence from the Nurses\u2019 Health Study. Cancer. 2000;89(11):2176\u201386. https:\/\/doi.org\/10.1002\/1097-0142(20001201)89:11%3c2176::aid-cncr5%3e3.0.co;2-6.","journal-title":"Cancer"},{"issue":"6","key":"1220_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3109\/0284186X.2015.1127415","volume":"55","author":"RV Karlsen","year":"2016","unstructured":"Karlsen RV, Frederiksen K, Larsen MB, von Heymann-Horan AB, Appel CW, Christensen J, et al. The impact of a breast cancer diagnosis on health-related quality of life. A prospective comparison among middle-aged to elderly women with and without breast cancer. Acta Oncol. 2016;55(6):720\u20137. https:\/\/doi.org\/10.3109\/0284186X.2015.1127415.","journal-title":"Acta Oncol"},{"issue":"5","key":"1220_CR5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/jgs.16323","volume":"68","author":"YL Michael","year":"2020","unstructured":"Michael YL, Wu C, Pan K, Seguin-Fowler RA, Garcia DO, Zaslavsky O, et al. Postmenopausal breast cancer and physical function change: a difference-in-differences analysis. J Am Geriatr Soc. 2020;68(5):1029\u201336. https:\/\/doi.org\/10.1111\/jgs.16323.","journal-title":"J Am Geriatr Soc"},{"key":"1220_CR6","unstructured":"CDC. Cognitive impairement: a call for action, now! https:\/\/www.cdc.gov\/aging\/pdf\/cognitive_impairment\/cogimp_poilicy_final.pdf. 2011 [cited 2022 April 15]."},{"key":"1220_CR7","doi-asserted-by":"publisher","first-page":"770413","DOI":"10.3389\/fmolb.2021.770413","volume":"8","author":"Z Orszaghova","year":"2021","unstructured":"Orszaghova Z, Mego M, Chovanec M. Long-term cognitive dysfunction in cancer survivors. Front Mol Biosci. 2021;8:770413. https:\/\/doi.org\/10.3389\/fmolb.2021.770413.","journal-title":"Front Mol Biosci"},{"issue":"3","key":"1220_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ctrv.2012.11.001","volume":"39","author":"KD Hodgson","year":"2013","unstructured":"Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev. 2013;39(3):297\u2013304. https:\/\/doi.org\/10.1016\/j.ctrv.2012.11.001.","journal-title":"Cancer Treat Rev"},{"issue":"29","key":"1220_CR9","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1200\/JCO.2011.39.5640","volume":"30","author":"HS Jim","year":"2012","unstructured":"Jim HS, Phillips KM, Chait S, Faul LA, Popa MA, Lee YH, et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol. 2012;30(29):3578\u201387. https:\/\/doi.org\/10.1200\/JCO.2011.39.5640.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1220_CR10","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/annonc\/mdz410","volume":"30","author":"M Lange","year":"2019","unstructured":"Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, et al. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol. 2019;30(12):1925\u201340. https:\/\/doi.org\/10.1093\/annonc\/mdz410.","journal-title":"Ann Oncol"},{"issue":"3","key":"1220_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10549-016-3906-9","volume":"158","author":"PE Lee","year":"2016","unstructured":"Lee PE, Tierney MC, Wu W, Pritchard KI, Rochon PA. Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies. Breast Cancer Res Treat. 2016;158(3):407\u201320. https:\/\/doi.org\/10.1007\/s10549-016-3906-9.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1220_CR12","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/cam4.174","volume":"3","author":"O Shibayama","year":"2014","unstructured":"Shibayama O, Yoshiuchi K, Inagaki M, Matsuoka Y, Yoshikawa E, Sugawara Y, et al. Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy. Cancer Med. 2014;3(3):702\u20139. https:\/\/doi.org\/10.1002\/cam4.174.","journal-title":"Cancer Med"},{"issue":"5","key":"1220_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/pon.5623","volume":"30","author":"ABC Dijkshoorn","year":"2021","unstructured":"Dijkshoorn ABC, van Stralen HE, Sloots M, Schagen SB, Visser-Meily JMA, Schepers VPM. Prevalence of cognitive impairment and change in patients with breast cancer: a systematic review of longitudinal studies. Psychooncology. 2021;30(5):635\u201348. https:\/\/doi.org\/10.1002\/pon.5623.","journal-title":"Psychooncology"},{"issue":"1","key":"1220_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11682-016-9665-8","volume":"12","author":"T Billiet","year":"2018","unstructured":"Billiet T, Emsell L, Vandenbulcke M, Peeters R, Christiaens D, Leemans A, et al. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors? Brain Imaging Behav. 2018;12(1):64\u201377. https:\/\/doi.org\/10.1007\/s11682-016-9665-8.","journal-title":"Brain Imaging Behav"},{"issue":"29","key":"1220_CR15","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1200\/Jco.2009.27.0827","volume":"28","author":"TA Ahles","year":"2010","unstructured":"Ahles TA, Saykin AJ, McDonald BC, Li YL, Furstenberg CT, Hanscom BS, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol. 2010;28(29):4434\u201340. https:\/\/doi.org\/10.1200\/Jco.2009.27.0827.","journal-title":"J Clin Oncol"},{"issue":"14","key":"1220_CR16","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1002\/cncr.25098","volume":"116","author":"JS Wefel","year":"2010","unstructured":"Wefel JS, Saleeba AK, Buzdar AU, Meyers CA. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010;116(14):3348\u201356. https:\/\/doi.org\/10.1002\/cncr.25098.","journal-title":"Cancer"},{"issue":"10","key":"1220_CR17","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1200\/Jco.2011.37.0189","volume":"30","author":"V Koppelmans","year":"2012","unstructured":"Koppelmans V, Breteler MMB, Boogerd W, Seynaeve C, Gundy C, Schagen SB. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol. 2012;30(10):1080\u20136. https:\/\/doi.org\/10.1200\/Jco.2011.37.0189.","journal-title":"J Clin Oncol"},{"issue":"11","key":"1220_CR18","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/ggi.14040","volume":"20","author":"A Sardella","year":"2020","unstructured":"Sardella A, Catalano A, Lenzo V, Bellone F, Corica F, Quattropani MC, et al. Association between cognitive reserve dimensions and frailty among older adults: a structured narrative review. Geriatr Gerontol Int. 2020;20(11):1005\u201323. https:\/\/doi.org\/10.1111\/ggi.14040.","journal-title":"Geriatr Gerontol Int"},{"issue":"22","key":"1220_CR19","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1002\/cncr.30208","volume":"122","author":"JS Mandelblatt","year":"2016","unstructured":"Mandelblatt JS, Clapp JD, Luta G, Faul LA, Tallarico MD, McClendon TD, et al. Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance). Cancer. 2016;122(22):3555\u201363. https:\/\/doi.org\/10.1002\/cncr.30208.","journal-title":"Cancer"},{"issue":"8","key":"1220_CR20","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/hbm.21102","volume":"32","author":"MB de Ruiter","year":"2011","unstructured":"de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, van Dam FS, Nederveen AJ, et al. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp. 2011;32(8):1206\u201319. https:\/\/doi.org\/10.1002\/hbm.21102.","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"1220_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10549-006-9380-z","volume":"103","author":"DH Silverman","year":"2007","unstructured":"Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5\u201310 years after chemotherapy. Breast Cancer Res Treat. 2007;103(3):303\u201311. https:\/\/doi.org\/10.1007\/s10549-006-9380-z.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"1220_CR22","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1002\/hbm.21422","volume":"33","author":"MB de Ruiter","year":"2012","unstructured":"de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, et al. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp. 2012;33(12):2971\u201383. https:\/\/doi.org\/10.1002\/hbm.21422.","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"1220_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11910-012-0264-9","volume":"12","author":"JS Wefel","year":"2012","unstructured":"Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012;12(3):267\u201375. https:\/\/doi.org\/10.1007\/s11910-012-0264-9.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"1220_CR24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jama.1990.03440050059033","volume":"263","author":"SR Cummings","year":"1990","unstructured":"Cummings SR, Black DM, Nevitt MC, Browner WS, Cauley JA, Genant HK, et al. Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA. 1990;263(5):665\u20138.","journal-title":"JAMA"},{"issue":"6","key":"1220_CR25","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/archinte.156.6.630","volume":"156","author":"MT Vogt","year":"1996","unstructured":"Vogt MT, Cauley JA, Scott JC, Kuller LH, Browner WS. Smoking and mortality among older women - the study of osteoporotic fractures. Arch Intern Med. 1996;156(6):630\u20136. https:\/\/doi.org\/10.1001\/archinte.156.6.630.","journal-title":"Arch Intern Med"},{"issue":"17","key":"1220_CR26","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1001\/jama.1996.03540170048031","volume":"276","author":"JA Cauley","year":"1996","unstructured":"Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA. 1996;276(17):1404\u20138.","journal-title":"JAMA"},{"key":"1220_CR27","unstructured":"Grandits G and Neuhaus J. Using SAS\u00ae to perform individual matching in design of case-control studies https:\/\/support.sas.com\/resources\/papers\/proceedings10\/061-2010.pdf. in SAS Global Forum. 2010. Accessed 1 March 2022"},{"issue":"7","key":"1220_CR28","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/archpsyc.1983.01790060110016","volume":"40","author":"MF Folstein","year":"1983","unstructured":"Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry. 1983;40(7):812. https:\/\/doi.org\/10.1001\/archpsyc.1983.01790060110016.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"1220_CR29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1076\/1380-3395(200008)22:4;1-0;Ft518","volume":"22","author":"K Arbuthnott","year":"2000","unstructured":"Arbuthnott K, Frank J. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol. 2000;22(4):518\u201328. https:\/\/doi.org\/10.1076\/1380-3395(200008)22:4;1-0;Ft518.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"5","key":"1220_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1037\/h0044509","volume":"19","author":"RM Reitan","year":"1955","unstructured":"Reitan RM. The relation of the trail making test to organic brain damage. J Consult Psychol. 1955;19(5):393\u20134. https:\/\/doi.org\/10.1037\/h0044509.","journal-title":"J Consult Psychol"},{"issue":"4","key":"1220_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/gerona\/61.4.405","volume":"61","author":"T Blackwell","year":"2006","unstructured":"Blackwell T, Yaffe K, Ancoli-Israel S, Scheider JL, Cauley JA, Hillier TA, et al. Poor sleep is associated with impaired cognitive function in older women: the Study of Osteoporotic Fractures. Journals of Gerontology Series a-Biological Sciences and Medical Sciences. 2006;61(4):405\u201310. https:\/\/doi.org\/10.1093\/gerona\/61.4.405.","journal-title":"Journals of Gerontology Series a-Biological Sciences and Medical Sciences"},{"key":"1220_CR32","unstructured":"Warton EM. Time after time: difference-in-differences and interrupted time series models in SAS. in SAS Global Forum 2020. 2020.\u00a0https:\/\/www.sas.com\/content\/dam\/SAS\/support\/en\/sas-global-forum-proceedings\/2020\/4674-2020.pdf."},{"issue":"2","key":"1220_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10549-017-4627-4","volume":"168","author":"EA Underwood","year":"2018","unstructured":"Underwood EA, Rochon PA, Moineddin R, Lee PE, Wu W, Pritchard KI, et al. Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis. Breast Cancer Res Treat. 2018;168(2):299\u2013310. https:\/\/doi.org\/10.1007\/s10549-017-4627-4.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"1220_CR34","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/gerona\/glt195","volume":"70","author":"KJ Anstey","year":"2015","unstructured":"Anstey KJ, Sargent-Cox K, Cherbuin N, Sachdev PS. Self-reported history of chemotherapy and cognitive decline in adults aged 60 and older: the PATH through life project. J Gerontol Ser a-Biol Sci Med Sci. 2015;70(6):729\u201335. https:\/\/doi.org\/10.1093\/gerona\/glt195.","journal-title":"J Gerontol Ser a-Biol Sci Med Sci"},{"issue":"11","key":"1220_CR35","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1634\/theoncologist.2016-0014","volume":"21","author":"M Lange","year":"2016","unstructured":"Lange M, Heutte N, Rigal O, Noal S, Kurtz JE, Levy C, et al. Decline in cognitive function in older adults with early-stage breast cancer after adjuvant treatment. Oncologist. 2016;21(11):1337\u201348. https:\/\/doi.org\/10.1634\/theoncologist.2016-0014.","journal-title":"Oncologist"},{"issue":"1","key":"1220_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1365-2354.2008.01018.x","volume":"19","author":"EA Kvale","year":"2010","unstructured":"Kvale EA, Clay OJ, Ross-Meadows LA, McGee JS, Edwards JD, Unverzagt FW, et al. Cognitive speed of processing and functional declines in older cancer survivors: an analysis of data from the ACTIVE trial. Eur J Cancer Care (Engl). 2010;19(1):110\u20137. https:\/\/doi.org\/10.1111\/j.1365-2354.2008.01018.x.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"1220_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuropharm.2013.11.012","volume":"79","author":"M Dubois","year":"2014","unstructured":"Dubois M, Lapinte N, Villier V, Lecointre C, Roy V, Tonon MC, et al. Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: role of glucose as adjuvant. Neuropharmacology. 2014;79:234\u201348. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.11.012.","journal-title":"Neuropharmacology"},{"issue":"6","key":"1220_CR38","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s11682-019-00074-y","volume":"13","author":"Y Feng","year":"2019","unstructured":"Feng Y, Zhang XD, Zheng G, Zhang LJ. Chemotherapy-induced brain changes in breast cancer survivors: evaluation with multimodality magnetic resonance imaging. Brain Imaging Behav. 2019;13(6):1799\u2013814. https:\/\/doi.org\/10.1007\/s11682-019-00074-y.","journal-title":"Brain Imaging Behav"},{"issue":"1","key":"1220_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5114\/wo.2017.66652","volume":"21","author":"P Andryszak","year":"2017","unstructured":"Andryszak P, Wilkosc M, Izdebski P, Zurawski B. A systemic literature review of neuroimaging studies in women with breast cancer treated with adjuvant chemotherapy. Contemp Oncol (Pozn). 2017;21(1):6\u201315. https:\/\/doi.org\/10.5114\/wo.2017.66652.","journal-title":"Contemp Oncol (Pozn)"},{"issue":"3","key":"1220_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.nbd.2012.07.009","volume":"48","author":"J Bruno","year":"2012","unstructured":"Bruno J, Hosseini SM, Kesler S. Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors. Neurobiol Dis. 2012;48(3):329\u201338. https:\/\/doi.org\/10.1016\/j.nbd.2012.07.009.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1220_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13058-018-1062-3","volume":"20","author":"KD van der Willik","year":"2018","unstructured":"van der Willik KD, Koppelmans V, Hauptmann M, Compter A, Ikram MA, Schagen SB. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study. Breast Cancer Res. 2018;20(1):135. https:\/\/doi.org\/10.1186\/s13058-018-1062-3.","journal-title":"Breast Cancer Res"},{"issue":"Suppl","key":"1220_CR42","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/j.bbi.2012.05.017","volume":"30","author":"S Kesler","year":"2013","unstructured":"Kesler S, Janelsins M, Koovakkattu D, Palesh O, Mustian K, Morrow G, et al. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun. 2013;30(Suppl):S109\u201316. https:\/\/doi.org\/10.1016\/j.bbi.2012.05.017.","journal-title":"Brain Behav Immun"},{"issue":"7","key":"1220_CR43","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/annonc\/mdv206","volume":"26","author":"YT Cheung","year":"2015","unstructured":"Cheung YT, Ng T, Shwe M, Ho HK, Foo KM, Cham MT, et al. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Ann Oncol. 2015;26(7):1446\u201351. https:\/\/doi.org\/10.1093\/annonc\/mdv206.","journal-title":"Ann Oncol"},{"issue":"6","key":"1220_CR44","first-page":"3046","volume":"12","author":"JJ Zhao","year":"2020","unstructured":"Zhao JJ, Zuo H, Ding K, Zhang XQ, Bi ZR, Cheng HD. Changes in plasma IL-1 beta, TNF-alpha and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients. Am J Transl Res. 2020;12(6):3046\u201356.","journal-title":"Am J Transl Res"},{"issue":"10","key":"1220_CR45","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1007\/s12035-019-1589-z","volume":"56","author":"C Bagnall-Moreau","year":"2019","unstructured":"Bagnall-Moreau C, Chaudhry S, Salas-Ramirez K, Ahles T, Hubbard K. Chemotherapy-induced cognitive impairment is associated with increased inflammation and oxidative damage in the hippocampus. Mol Neurobiol. 2019;56(10):7159\u201372. https:\/\/doi.org\/10.1007\/s12035-019-1589-z.","journal-title":"Mol Neurobiol"},{"issue":"9","key":"1220_CR46","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1007\/s00520-019-04866-2","volume":"27","author":"HA Fernandes","year":"2019","unstructured":"Fernandes HA, Richard NM, Edelstein K. Cognitive rehabilitation for cancer-related cognitive dysfunction: a systematic review. Support Care Cancer. 2019;27(9):3253\u201379. https:\/\/doi.org\/10.1007\/s00520-019-04866-2.","journal-title":"Support Care Cancer"},{"issue":"1","key":"1220_CR47","doi-asserted-by":"publisher","first-page":"150977","DOI":"10.1016\/j.soncn.2019.150977","volume":"36","author":"D Von Ah","year":"2020","unstructured":"Von Ah D, Crouch A. Cognitive rehabilitation for cognitive dysfunction after cancer and cancer treatment: implications for nursing practice. Semin Oncol Nurs. 2020;36(1):150977. https:\/\/doi.org\/10.1016\/j.soncn.2019.150977.","journal-title":"Semin Oncol Nurs"},{"issue":"3","key":"1220_CR48","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/ptj\/pzz090","volume":"100","author":"KL Campbell","year":"2020","unstructured":"Campbell KL, Zadravec K, Bland KA, Chesley E, Wolf F, Janelsins MC. The effect of exercise on cancer-related cognitive impairment and applications for physical therapy: systematic review of randomized controlled trials. Phys Ther. 2020;100(3):523\u201342. https:\/\/doi.org\/10.1093\/ptj\/pzz090.","journal-title":"Phys Ther"},{"issue":"8","key":"1220_CR49","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tins.2018.05.001","volume":"41","author":"TS Horowitz","year":"2018","unstructured":"Horowitz TS, Suls J, Trevino M. A call for a neuroscience approach to cancer-related cognitive impairment. Trends Neurosci. 2018;41(8):493\u20136. https:\/\/doi.org\/10.1016\/j.tins.2018.05.001.","journal-title":"Trends Neurosci"},{"issue":"2","key":"1220_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11065-020-09434-8","volume":"30","author":"HM Gavelin","year":"2020","unstructured":"Gavelin HM, Lampit A, Hallock H, Sabates J, Bahar-Fuchs A. Cognition-oriented treatments for older adults: a systematic overview of systematic reviews. Neuropsychol Rev. 2020;30(2):167\u201393. https:\/\/doi.org\/10.1007\/s11065-020-09434-8.","journal-title":"Neuropsychol Rev"},{"issue":"3","key":"1220_CR51","doi-asserted-by":"publisher","first-page":"154-+","DOI":"10.1136\/bjsports-2016-096587","volume":"52","author":"JM Northey","year":"2018","unstructured":"Northey JM, Cherbuin N, Pumpa KL, Smee DJ, Rattray B. Exercise interventions for cognitive function in adults older than 50: a systematic review with meta-analysis. Br J Sports Med. 2018;52(3):154-+. https:\/\/doi.org\/10.1136\/bjsports-2016-096587.","journal-title":"Br J Sports Med"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-022-01220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-022-01220-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-022-01220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T06:10:41Z","timestamp":1695881441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-022-01220-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,28]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1220"],"URL":"https:\/\/doi.org\/10.1007\/s11764-022-01220-0","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,28]]},"assertion":[{"value":"21 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the Human Research Protection Program (HRPP) Office of Research Compliance \u2013 Indiana University, Protocol #: 2011885371.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"At each Study of Osteoporosis Fractures site, the institutional review boards approved the study. All participants provided written informed consent. The study was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We have no conflict of interests to declare.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}